StreetInsider.com News Articles

Form SCHEDULE 13G Co-Diagnostics, Inc. Filed by: JANE STREET GROUP, LLC

Wed, 03 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260603/26599213.html

Form SCHEDULE 13G Co-Diagnostics, Inc. Filed by: JANE STREET GROUP, LLC

Wed, 03 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260603/26599213.html

Co-Diagnostics advances Ebola PCR test development with CoSara venture

Tue, 02 Jun 2026 09:01:08 -0400

Co-Diagnostics, Inc. (NASDAQ: CODX) announced progress in developing Ebola PCR tests through its joint venture with CoSara Diagnostics Pvt. Ltd., according to a company statement.

The program includes two assay types: a pan-Ebola assay designed to detect multiple ebolavirus species and a multiplex assay capable of differentiating among Sudan, Taï Forest, Zaire, and Bundibugyo ebolaviruses associated with outbreaks in Central Africa.

The dual-assay strategy is intended to support outbreak response efforts, including those of potential NGO partners, subject to future development, validation, regulatory review, and deployment requirements.

"Our ability to rapidly develop and deploy molecular diagnostic solutions for emerging infectious disease threats is

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Tue, 02 Jun 2026 09:00:00 -0400

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regions

Potential blood-based Ebola assay would represent an important expansion of Co-Dx™ PCR point-of-care platform capabilities

SALT LAKE CITY, June 2, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced continued progress in its Ebola PCR development program with joint venture CoSara Diagnostics Pvt. Ltd. ("CoSara" or the "JV"). The program includes development of both

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Tue, 02 Jun 2026 09:00:00 -0400

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regions

Potential blood-based Ebola assay would represent an important expansion of Co-Dx™ PCR point-of-care platform capabilities

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Tue, 02 Jun 2026 09:00:00 -0400

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regions

Potential blood-based Ebola assay would represent an important expansion of Co-Dx™ PCR point-of-care platform capabilities

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Tue, 02 Jun 2026 09:00:00 -0400

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regions

Potential blood-based Ebola assay would represent an important expansion of Co-Dx™ PCR point-of-care platform capabilities

Form EFFECT Co-Diagnostics, Inc.

Mon, 01 Jun 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260601/26578486.html

Form EFFECT Co-Diagnostics, Inc.

Mon, 01 Jun 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260601/26578486.html

Form S-3 Co-Diagnostics, Inc.

Thu, 28 May 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260528/26568006.html

Form S-3 Co-Diagnostics, Inc.

Thu, 28 May 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260528/26568006.html

Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Egan Dwight H

Wed, 27 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260527/26557723.html

Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Egan Dwight H

Wed, 27 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260527/26557723.html

Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Abbott Richard David

Wed, 27 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260527/26557676.html

Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Abbott Richard David

Wed, 27 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260527/26557676.html

Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Brown Brian Lee

Wed, 27 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260527/26557684.html

Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Brown Brian Lee

Wed, 27 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260527/26557684.html

Form 4 Co-Diagnostics, Inc. For: May 27 Filed by: Durenard Eugene